Literature DB >> 29219952

Early onset posterior subscapular cataract in a series of myotonic dystrophy type 2 patients.

C Papadopoulos1, K Kekou2, S Xirou1, S Kitsiou-Tzeli2, E Kararizou1, G K Papadimas1.   

Abstract

PurposeEarly onset posterior subscapular cataract (<50 years of age) is a characteristic feature of myotonic dystrophy type 2 (DM2). Nevertheless, despite being operated at a young age, many patients remain undiagnosed for years. The purpose of this study was to assess the prevalence of early onset posterior subscapular cataract as a presenting symptom of the disease in a cohort of patients with DM2.Patients and methodsWe retrospectively reviewed medical records of DM2 patients followed in our institution for the presence of early onset posterior subscapular cataract, of any secondary causes of cataract, of the age of onset of muscle weakness and of final disease diagnosis.ResultsTwenty-eight patients were studied. Nine patients (32.1%) had presented early onset posterior subscapular cataract at a median age of 43 years (IQR=36-46) and seven (25%) reported it was the presenting sign. No patient was referred for neuromuscular evaluation due to the occurrence of early onset cataract. Median delay between cataract onset and referral for neuromuscular evaluation was 10 years (IQR=6.0-19.5) and final DM2 diagnosis was achieved after a median of 16 years (IQR=6.5-19.5).ConclusionThis study shows that early onset posterior subscapular cataract was the first symptom of the disease in 25% of our DM2 patients. Nevertheless, none was suspected of having cataract in the context of DM2, and referral for neuromuscular evaluation was made after a long delay and usually following the appearance of other symptoms. Ophthalmologists can be the first physicians encountering these patients and should have a low threshold for referring them for neuromuscular evaluation.

Entities:  

Mesh:

Year:  2017        PMID: 29219952      PMCID: PMC5848294          DOI: 10.1038/eye.2017.280

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

1.  Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands.

Authors:  B Udd; G Meola; R Krahe; C Thornton; L Ranum; J Day; G Bassez; K Ricker
Journal:  Neuromuscul Disord       Date:  2003-09       Impact factor: 4.296

2.  Diagnostic odyssey of patients with myotonic dystrophy.

Authors:  James E Hilbert; Tetsuo Ashizawa; John W Day; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  J Neurol       Date:  2013-06-27       Impact factor: 4.849

3.  Proximal myotonic dystrophy--a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes?

Authors:  B Udd; R Krahe; C Wallgren-Pettersson; B Falck; H Kalimo
Journal:  Neuromuscul Disord       Date:  1997-06       Impact factor: 4.296

4.  Patients with primary cataract as a genetic pool of DMPK protomutation.

Authors:  Igor Medica; Natasa Teran; Marija Volk; Vladimir Pfeifer; Edi Ladavac; Borut Peterlin
Journal:  J Hum Genet       Date:  2006-12-05       Impact factor: 3.172

Review 5.  The myotonic dystrophies: diagnosis and management.

Authors:  Chris Turner; David Hilton-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-02-22       Impact factor: 10.154

6.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

7.  Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2).

Authors:  J W Day; R Roelofs; B Leroy; I Pech; K Benzow; L P Ranum
Journal:  Neuromuscul Disord       Date:  1999-01       Impact factor: 4.296

8.  Proximal myotonic myopathy (PROMM) and other proximal myotonic syndromes.

Authors:  R T Moxley; B Udd; K Ricker
Journal:  Neuromuscul Disord       Date:  1998-10       Impact factor: 4.296

Review 9.  Myotonic dystrophy type 2.

Authors:  J Finsterer
Journal:  Eur J Neurol       Date:  2002-09       Impact factor: 6.089

10.  Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts.

Authors:  K Ricker; M C Koch; F Lehmann-Horn; D Pongratz; M Otto; R Heine; R T Moxley
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

View more
  6 in total

1.  Christmas tree cataract and myotonic dystrophy type 1.

Authors:  Dionysios Pagoulatos; Zoi Kapsala; Olga E Makri; Constantinos D Georgakopoulos
Journal:  Eye (Lond)       Date:  2018-07-09       Impact factor: 3.775

2.  Risk Factor Analysis of Early-Onset Cataracts in Taiwan.

Authors:  Lung-Hui Tsai; Ching-Chung Chen; Chien-Ju Lin; Sheng-Pei Lin; Ching-Ying Cheng; Hsi-Pao Hsieh
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

3.  Efficacy and safety of ropivacaine HCl in peribulbar anaesthesia for cataract surgery in patients with myotonic dystrophy type 1.

Authors:  Alberto Palladino; Maddalena De Bernardo; Marianna Scutifero; Michele Lanza; Silvio De Querquis; Nicola Rosa; Luisa Politano
Journal:  Acta Myol       Date:  2020-06-01

4.  Myotonic dystrophy type 2: the 2020 update.

Authors:  Giovanni Meola
Journal:  Acta Myol       Date:  2020-12-01

Review 5.  Cellular Senescence and Aging in Myotonic Dystrophy.

Authors:  Yuhei Hasuike; Hideki Mochizuki; Masayuki Nakamori
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

6.  Ocular Features and Clinical Approach to Cataract and Corneal Refractive Surgery in Patients with Myotonic Dystrophy.

Authors:  Majid Moshirfar; Court R Webster; Tanner S Seitz; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Clin Ophthalmol       Date:  2022-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.